Uni of Chi Medi Ctr Hema and Onco — Chicago, Illinois

Uni of Chi Medi Ctr Hema and Onco is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Uni of Chi Medi Ctr Hema and Onco has participated in 7 clinical trials with 4 currently active.

Therapeutic areas: Primary Immune Thrombocytopenia (ITP), Multiple Myeloma, Chronic Lymphocytic Leukemia.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Uni of Chi Medi Ctr Hema and Onco?

Uni of Chi Medi Ctr Hema and Onco has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Uni of Chi Medi Ctr Hema and Onco conducted?

Uni of Chi Medi Ctr Hema and Onco has 7 clinical trials on record, with 4 currently active. Their work covers Primary Immune Thrombocytopenia (ITP), Multiple Myeloma, Chronic Lymphocytic Leukemia.

Is Uni of Chi Medi Ctr Hema and Onco accredited by Crixeo Health?

Uni of Chi Medi Ctr Hema and Onco has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Uni of Chi Medi Ctr Hema and Onco?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.